Rocket


News + Filings
Transactions
Holdings



Abingworth LLP

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
03/29/2022SOLENO THERAPEUTICS INCSLNOPurchaseCommon Stock7.7M$0.00$0See Footnotes12/21/2018
03/29/2022SOLENO THERAPEUTICS INCSLNOPurchaseWarrant (right to buy)7.7M$0.30$2.3MSee footnotes12/21/2018
03/21/2022Jasper Therapeutics, Inc.AMHCUGrantStock Option (right to buy)78k$3.54$276.3kSee footnotes03/21/2022
01/31/2022Sierra Oncology, Inc.SRRAPurchaseCommon Stock, $0.001 par value150k$27.00$4MSee footnote01/28/2022
01/28/2022Sierra Oncology, Inc.SRRAExercise (in-the-money or at-the-money)Series B Warrants (right to buy)287.5k$13.20$3.8MSee footnote01/28/2022
10/06/2021eFFECTOR Therapeutics, Inc. GrantStock Option (right to buy)40k$11.36$454.4kSee Footnotes10/06/2021
06/01/2021SOLENO THERAPEUTICS INCSLNOGrantStock Option (right to buy)31.9k$1.02$32.5kSee footnotes12/21/2018
05/18/2021Vera Therapeutics, Inc. PurchaseClass A Common Stock772.7k$11.00$8.5MSee Footnote05/13/2021
05/18/2021Vera Therapeutics, Inc. ConversionClass A Common Stock2.2M$0.00$0See Footnote05/13/2021
05/13/2021Vera Therapeutics, Inc. GrantStock Option (right to buy)9.9k$11.00$109.2kSee footnotes05/13/2021
01/08/2021SOLENO THERAPEUTICS INCSLNOGrantStock Option (right to buy)40k$2.24$89.6kSee footnotes12/21/2018
10/20/2020Personalis, Inc.PSNLSaleCommon Stock, $0.0001 par value per share130.5k$27.66$3.6MSee Footnote10/20/2020
10/19/2020Personalis, Inc.PSNLSaleCommon Stock, $0.0001 par value per share196.4k$27.86$5.5MSee Footnote10/16/2020
10/16/2020Personalis, Inc.PSNLSaleCommon Stock, $0.0001 par value per share94.2k$26.68$2.5MSee Footnote10/16/2020
10/15/2020Personalis, Inc.PSNLSaleCommon Stock, $0.0001 par value per share3.7k$26.32$97.4kSee Footnote10/14/2020
10/14/2020Personalis, Inc.PSNLSaleCommon Stock, $0.0001 par value per share81.9k$27.08$2.2MSee Footnote10/14/2020
10/13/2020Personalis, Inc.PSNLSaleCommon Stock, $0.0001 par value per share86.8k$28.43$2.5MSee Footnote10/12/2020
10/12/2020Personalis, Inc.PSNLSaleCommon Stock, $0.0001 par value per share115.5k$29.09$3.4MSee Footnote10/12/2020
08/18/2020Personalis, Inc.PSNLSaleCommon Stock, $0.0001 par value per share986.8k$19.00$18.7MSee Footnote08/18/2020
06/26/2020SOLENO THERAPEUTICS INCSLNOPurchaseCommon Stock3.3M$1.65$5.5MSee Footnotes06/26/2020
06/11/2020Vaxcyte, Inc.PCVXGrantStock option (right to buy)40k$16.00$640kSee Footnotes06/11/2020
06/11/2020Vaxcyte, Inc.PCVXGrantStock option (right to buy)40k$16.00$640kSee Footnotes06/11/2020
05/18/2020SOLENO THERAPEUTICS INCSLNOGrantStock Option (right to buy)9.5k$3.41$32.5kSee footnotes12/21/2018
11/12/2019Protara Therapeutics, Inc.PRTOConversionSeries A Convertible Preferred Stock126$0.00$0See Footnote11/12/2019
11/12/2019Protara Therapeutics, Inc.PRTOConversionCommon Stock, $0.001 par value126.6k$0.99$126kSee Footnote11/12/2019
10/25/2019SOLENO THERAPEUTICS INCSLNOPurchaseCommon Stock2.3M$1.20$2.8MSee Footnote10/25/2019
06/24/2019Personalis, Inc.PSNLConversionCommon Stock, $0.0001 par value per share2.3M$0.00$0See Footnote06/24/2019
06/24/2019Personalis, Inc.PSNLConversionCommon Stock, $0.0001 par value per share878.4k$0.00$0See Footnote06/24/2019
06/24/2019Personalis, Inc.PSNLConversionCommon Stock, $0.0001 par value per share2.1M$0.00$0See Footnote06/24/2019
06/24/2019Personalis, Inc.PSNLConversionSeries A Preferred Stock2.3M$0.00$0See Footnote06/24/2019
06/24/2019Personalis, Inc.PSNLConversionSeries B Preferred Stock2.1M$0.00$0See Footnote06/24/2019
06/24/2019Personalis, Inc.PSNLConversionSeries C Preferred Stock878.4k$0.00$0See Footnote06/24/2019
06/10/2019SOLENO THERAPEUTICS INCSLNOGrantStock Option (right to buy)13k$2.50$32.5kSee footnotes12/21/2018
12/21/2018SOLENO THERAPEUTICS INCSLNOGrantStock Option (right to buy)20k$1.57$31.4kSee footnotes12/21/2018
06/08/2018Protara Therapeutics, Inc.PRTOGrantStock Option (Right to Buy)12.7k$2.50$31.8kBy affiliate06/08/2018
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy